Abstract
Aim:
To determine whether adeno-associated virus (AAV)-2-mediated, bone morphogenetic protein (BMP)-7-expressing human adipose-derived mesenchymal stem cells (ADMS) cells would induce bone formation in vitro and in vivo.
Methods:
ADMS cells were harvested from patients undergoing selective suction-assisted lipectomy and transduced with AAV carrying the human BMP-7 gene. Non-transduced cells and cells transduced with AAV serotype 2 carrying the enhanced green fluorescence protein gene served as controls. ADMS cells were qualitatively assessed for the production of BMP-7 and osteocalcin, and subjected to alkaline phosphatase (ALP) and Chinalizarin staining. A total of 2.5×106 cells mixed with type I collagen were implanted into the hind limb of severe combined immune-deficient (SCID) mice and subjected to a histological analysis 3 weeks post implantation.
Results:
Transfection of the ADMS cells achieved an efficiency of 99% at d 7. Transduction with AAV2-BMP-7 induced the expression of BMP-7 until d 56, which was markedly increased by d 7. The cells were positively stained for ALP. Osteocalcin production and matrix mineralization further confirmed that these cells differentiated into osteoblasts and induced bone formation in vitro. A histological examination demonstrated that implantation of BMP-7-expressing ADMS cells could induce new bone formation in vivo.
Conclusion:
The present in vitro and in vivo study demonstrated that human ADMS cells would be a promising source of autologous mesenchymal stem cells for BMP gene therapy and tissue engineering.
Similar content being viewed by others
Article PDF
References
Colterjohn NR, Bednar DA . Procurement of bone graft from the iliac crest: an operative approach with decreased morbidity. J Bone Joint Surg Am, 1997; 79: 756–9.
Gamradt, SC, Lieberman JR . Bone graft for revision hip arthroplasty: biology and future applications. Clin Orthop Relat Res 2003; ( 417): 183–94.
Hannallah D, Peterson B, Lieberman JR, Fu FH, Huard J . Gene therapy in orthopaedic surgery. J Bone Joint Surg Am, 2002; 84A: 1046–61.
Wozney, JM . Bone morphogenetic proteins. Prog Growth Factor Res, 1989; 1: 267–80.
Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, et al. Novel regulators of bone formation: molecular clones and activities. Science, 1988; 242: 1528–34.
Philips FM, Turner AS, Seim HB 3rd, MacLeay J, Toth CA, Pierce AR, et al. In vivo BMP-7 (OP-1) enhacement of osteoporotic vertebral bodies in an ovine model. Spine J, 2006; 6: 500–6.
Sugiyama O, An DS, Kung SPK, Feeley BT, Gamradt S, Liu NQ, et al. Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. Mol Ther 2005; 11: 390–8.
Pluhar GE, Turner AS, Pierce AR, Toth CA, Wheeler DL . A comparison of two biomaterial carriers for osteogenic protein-1 (BMP-7) in an ovine critical defect model. J Bone Surg Br, 2006; 88: 960–6.
Abe N, Lee YP, Sato M, Zhang X, Wu J, Mitani K, et al. Enhancement of bone repair with a helper-dependent adenoviral transfer of bone morphogenetic protein-2. Biochem Biophys Res Commun, 2002; 297: 523–7.
Lee JY, Peng H, Usas A, Musgrave D, Cummins J, Pelinkovic D, et al. Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2. Hum Gene Ther, 2002; 13: 1201–11.
Sugiyama O, Orimo H, Suzuki S, Yamashita K, Ito H, Shimada T, et al. Bone formation following transplantation of genetically modified primary bone marrow stromal cells. J Orthop Res, 2003; 21: 630–7.
Wilson JM . Adenoviruses as gene-delivery vehicles. N Engl J Med, 1996; 334: 1185–7.
Anderson WF . Human gene therapy. Nature, 1998; 392: 25–30.
Muzyczka N . Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Microbiol Immunol, 1992; 158: 97–129.
Samulski RJ, Chang LS, Shenk T . Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol, 1989; 63: 3822–8.
Stiehler M, Duch M, Mygind T, Li H, Ulrich-Vinther M, Modin C, et al. Optimizing viral and non-viral gene transfer methods for genetic modification of porcine mesenchymal stem cells. Adv Exp Med Biol, 2006; 585: 31–48.
Monahan PE, Samulski RJ . AAV vectors: is clinical success on the horizon? Gene Ther 2000; 7: 24–30.
Chen Y, Luk KD, Cheung KM, Xu R, Lin MC, Lu WW, et al. Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. Gene Ther, 2003; 10: 1345–53.
Luk KD, Chen Y, Cheung KM, Kung HF, Lu WW, Leong JC . Adeno-associated virus-mediated bone morphogenetic protein-4 gene therapy for in vivo bone formation. Biochem Biophys Res Commun, 2003; 308: 636–45.
Gafni Y, Pelled G, Zilberman Y, Turgeman G, Apparailly F, Yotvat H, et al. Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. Mol Ther, 2004; 9: 587–95.
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng, 2001; 7: 211–28.
De Ugarte DA, Ashjian PH, Elbarbary A, Hedrick MH . Future of fat as raw material for tissue regeneration. Ann Plast Surg, 2003; 50: 215–9.
Gronthos S, Franklin DM, Leddy HA, Robey PG, Storms RW, Gimble JM . Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol, 2001; 189: 54–63.
Lee JA, Parrett BM, Conejero JA, Laser J, Chen J, Kogon AJ, et al. Biological alchemy: engineering bone and fat from fat-derived mesenchymal stem cells. Ann Plast Surg, 2003; 50: 610–7.
Aust L, Devlin B, Foster SJ, Halvorsen YD, Hicok K, du Laney T, et al. Yield of human adipose-derived mesenchymal stem cells from liposuction aspirates. Cytotherapy, 2004; 6: 7–10.
Ponnazhagan S, Yoder MC, Srivastava A . Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo. J Virol 1997; 71: 3098–104.
Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent mesenchymal stem cells. Mol Biol Cell, 2002; 13: 4279–95.
Gronthos S, Franklin DM, Leddy HA, Robey PG, Storms RW, Gimble JM . Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol, 2001; 189: 54–63.
Cao Y, Sun Z, Liao L, Meng Y, Han Q, Zhao RC . Human adipose tissue-derived mesenchymal stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun 2005; 332: 370–9.
Li R, Wozney J . Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol, 2001; 19: 255–65.
Dragoo JL, Choi JY, Lieberman JR, Huang J, Zuk PA, Zhang J, et al. Bone induction by BMP-2 transduced mesenchymal stem cells derived from human fat. J Orthop Res, 2003; 21: 622–9.
Kawai M, Bessho K, Kaihara S, Sonobe J, Oda K, Iizuka T, et al. Ectopic bone formation by human bone morphogenetic protein-2 gene transfer to skeletal muscle using transcutaneous electroporation. Hum Gene Ther, 2003; 14: 1547–56.
Park J, Ries J, Gelse K, Kloss F, von der Mark K, Wiltfang J, et al. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes. Gene Ther, 2003; 10: 1089–98.
Betz OB, Betz VM, Nazarian A, Egermann M, Gerstenfeld LC, Einhorn TA, et al. Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Gene Ther 2007 Apr 26: [Epub ahead of print].
Lieberman JR, Daluiski A, Stevenson S, Wu L, McAllister P, Lee YP, et al. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am, 1999; 81: 905–17.
Hidaka C, Goshi K, Rawlins B, Boachie-Adjei O, Crystal RG . Enhancement of spine fusion using combined gene therapy and tissue engineering BMP-7-expressing bone marrow cells and allograft bone. Spine, 2003; 28: 2049–57.
Wang JC, Kanim LE, Yoo S, Campbell PA, Berk AJ, Lieberman JR . Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. J Bone Joint Surg Am, 2003; 85: 905–11.
Amalfitano A, Parks RJ . Separating fact from fiction: assessing the potential of modified adenovirus vectors for use in human gene therapy. Curr Gene Ther, 2002; 2: 111–33.
Yang M, Ma QJ, Dang GT, Ma K, Chen P, Zhou CY . In vitro and in vivo induction of bone formation based on ex vivo gene therapy using rat adipose-derived mesenchymal stem cells expressing BMP-7. Cytotherapy, 2005; 7: 273–81.
Kay MA, Manno CS, Ragni MV, Larson PJ, Couto LB, McClelland A, et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet, 2000; 24: 257–61.
Aubert D, Pichard V, Durand S, Moullier P, Ferry N . Cytotoxic immune response after retroviral-mediated hepatic gene transfer in rat does not preclude expression from adeno-associated virus 1 transduced muscles. Hum Gene Ther, 2003; 14: 473–81.
Asahina I, Sampath TK, Hauschka PV . Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res, 1996; 222: 38–47.
Lee JY, Musgrave D, Pelinkovic D, Fukushima K, Cummins J, Usas A, et al. Effect of bone morphogenetic protein-2-express-ing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg Am, 2001; 83: 1032–9.
Noel D, Gazit D, Bouquet C, Apparailly F, Bony C, Plence P, Millet V, et al. Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal mesenchymal stem cells. Mesenchymal Stem Cells, 2004; 22: 74–85.
Moutsatsos IK, Turgeman G, Zhou S, Kurkalli BG, Pelled G, Tzur L, et al. Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther, 2001; 3: 449–61.
Peng H, Usas A, Gearhart B, Young B, Olshanski A, Huard J, et al. Development of a self-inactivating Tet-On retroviral vector expressing bone morphogenetic protein 4 to achieve regulated bone formation. Mol Ther, 2004; 9: 885–94.
Author information
Authors and Affiliations
Corresponding author
Additional information
This project was supported by a grant from the Guangdong Province Science Committee Foundation of China (No C30307).
Rights and permissions
About this article
Cite this article
Kang, Y., Liao, Wm., Yuan, Zh. et al. In vitro and in vivo induction of bone formation based on adeno-associated virus-mediated BMP-7 gene therapy using human adipose-derived mesenchymal stem cells. Acta Pharmacol Sin 28, 839–849 (2007). https://doi.org/10.1111/j.1745-7254.2007.00583.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00583.x
Keywords
This article is cited by
-
Ubiquitin-specific protease 53 promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells
Cell Death & Disease (2021)
-
Limited potential of AAV-mediated gene therapy in transducing human mesenchymal stem cells for bone repair applications
Gene Therapy (2021)
-
Bone Morphogenic Protein-7 Contributes to Cerebral Ischemic Preconditioning Induced-Ischemic Tolerance by Activating p38 Mitogen-Activated Protein Kinase Signaling Pathway
Inflammation (2014)
-
In vitro evaluation of a double-stranded self-complementary adeno-associated virus type2 vector in bone marrow stromal cells for bone healing
Genetic Vaccines and Therapy (2011)
-
Analysis of Adeno-associated Virus Progenitor Cell Transduction in Mouse Lung
Molecular Therapy (2009)